Cargando…
Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease
BACKGROUND: Cerebral small vessel disease (CSVD) is a cluster of microvascular disorders with unclear pathological mechanisms. The microbiota-gut-brain axis is an essential regulatory mechanism between gut microbes and their host. Therefore, the compositional and functional gut microbiota alteration...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366612/ https://www.ncbi.nlm.nih.gov/pubmed/37496806 http://dx.doi.org/10.3389/fcimb.2023.1231541 |
_version_ | 1785077205425979392 |
---|---|
author | Shi, Yachen Zhao, En Li, Lei Zhao, Songyun Mao, Haixia Deng, Jingyu Ji, Wei Li, Yang Gao, Qianqian Zeng, Siyuan Ma, Lin Xi, Guangjun You, Yiping Shao, Junfei Fang, Xiangming Wang, Feng |
author_facet | Shi, Yachen Zhao, En Li, Lei Zhao, Songyun Mao, Haixia Deng, Jingyu Ji, Wei Li, Yang Gao, Qianqian Zeng, Siyuan Ma, Lin Xi, Guangjun You, Yiping Shao, Junfei Fang, Xiangming Wang, Feng |
author_sort | Shi, Yachen |
collection | PubMed |
description | BACKGROUND: Cerebral small vessel disease (CSVD) is a cluster of microvascular disorders with unclear pathological mechanisms. The microbiota-gut-brain axis is an essential regulatory mechanism between gut microbes and their host. Therefore, the compositional and functional gut microbiota alterations lead to cerebrovascular disease pathogenesis. The current study aims to determine the alteration and clinical value of the gut microbiota in CSVD patients. METHODS: Sixty-four CSVD patients and 18 matched healthy controls (HCs) were included in our study. All the participants underwent neuropsychological tests, and the multi-modal magnetic resonance imaging depicted the changes in brain structure and function. Plasma samples were collected, and the fecal samples were analyzed with 16S rRNA gene sequencing. RESULTS: Based on the alpha diversity analysis, the CSVD group had significantly decreased Shannon and enhanced Simpson compared to the HC group. At the genus level, there was a significant increase in the relative abundances of Parasutterella, Anaeroglobus, Megasphaera, Akkermansia, Collinsella, and Veillonella in the CSVD group. Moreover, these genera with significant differences in CSVD patients revealed significant correlations with cognitive assessments, plasma levels of the blood-brain barrier-/inflammation-related indexes, and structural/functional magnetic resonance imaging changes. Functional prediction demonstrated that lipoic acid metabolism was significantly higher in CSVD patients than HCs. Additionally, a composite biomarker depending on six gut microbiota at the genus level displayed an area under the curve of 0.834 to distinguish CSVD patients from HCs using the least absolute shrinkage and selection operator (LASSO) algorithm. CONCLUSION: The evident changes in gut microbiota composition in CSVD patients were correlated with clinical features and pathological changes of CSVD. Combining these gut microbiota using the LASSO algorithm helped identify CSVD accurately. |
format | Online Article Text |
id | pubmed-10366612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103666122023-07-26 Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease Shi, Yachen Zhao, En Li, Lei Zhao, Songyun Mao, Haixia Deng, Jingyu Ji, Wei Li, Yang Gao, Qianqian Zeng, Siyuan Ma, Lin Xi, Guangjun You, Yiping Shao, Junfei Fang, Xiangming Wang, Feng Front Cell Infect Microbiol Cellular and Infection Microbiology BACKGROUND: Cerebral small vessel disease (CSVD) is a cluster of microvascular disorders with unclear pathological mechanisms. The microbiota-gut-brain axis is an essential regulatory mechanism between gut microbes and their host. Therefore, the compositional and functional gut microbiota alterations lead to cerebrovascular disease pathogenesis. The current study aims to determine the alteration and clinical value of the gut microbiota in CSVD patients. METHODS: Sixty-four CSVD patients and 18 matched healthy controls (HCs) were included in our study. All the participants underwent neuropsychological tests, and the multi-modal magnetic resonance imaging depicted the changes in brain structure and function. Plasma samples were collected, and the fecal samples were analyzed with 16S rRNA gene sequencing. RESULTS: Based on the alpha diversity analysis, the CSVD group had significantly decreased Shannon and enhanced Simpson compared to the HC group. At the genus level, there was a significant increase in the relative abundances of Parasutterella, Anaeroglobus, Megasphaera, Akkermansia, Collinsella, and Veillonella in the CSVD group. Moreover, these genera with significant differences in CSVD patients revealed significant correlations with cognitive assessments, plasma levels of the blood-brain barrier-/inflammation-related indexes, and structural/functional magnetic resonance imaging changes. Functional prediction demonstrated that lipoic acid metabolism was significantly higher in CSVD patients than HCs. Additionally, a composite biomarker depending on six gut microbiota at the genus level displayed an area under the curve of 0.834 to distinguish CSVD patients from HCs using the least absolute shrinkage and selection operator (LASSO) algorithm. CONCLUSION: The evident changes in gut microbiota composition in CSVD patients were correlated with clinical features and pathological changes of CSVD. Combining these gut microbiota using the LASSO algorithm helped identify CSVD accurately. Frontiers Media S.A. 2023-07-11 /pmc/articles/PMC10366612/ /pubmed/37496806 http://dx.doi.org/10.3389/fcimb.2023.1231541 Text en Copyright © 2023 Shi, Zhao, Li, Zhao, Mao, Deng, Ji, Li, Gao, Zeng, Ma, Xi, You, Shao, Fang and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Shi, Yachen Zhao, En Li, Lei Zhao, Songyun Mao, Haixia Deng, Jingyu Ji, Wei Li, Yang Gao, Qianqian Zeng, Siyuan Ma, Lin Xi, Guangjun You, Yiping Shao, Junfei Fang, Xiangming Wang, Feng Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease |
title | Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease |
title_full | Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease |
title_fullStr | Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease |
title_full_unstemmed | Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease |
title_short | Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease |
title_sort | alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366612/ https://www.ncbi.nlm.nih.gov/pubmed/37496806 http://dx.doi.org/10.3389/fcimb.2023.1231541 |
work_keys_str_mv | AT shiyachen alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT zhaoen alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT lilei alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT zhaosongyun alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT maohaixia alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT dengjingyu alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT jiwei alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT liyang alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT gaoqianqian alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT zengsiyuan alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT malin alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT xiguangjun alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT youyiping alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT shaojunfei alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT fangxiangming alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease AT wangfeng alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease |